This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Robert Salomon

Robert Salomon

Councilor (2020-2024)

As a multidisciplinary scientist, I am motivated to drive the advancement of science through the appropriate use of technology and am dedicated to building strong interdisciplinary teams to answer big questions in biology. I was one of the first to integrate single-cell genomic platforms (genomic cytometry) into conventional cytometry SRL, which resulted in the creation of the Garvan Weizmann Centre for Single-Cell Genomics). I designed technology pipelines for the ACRF Child Cancer Liquid Biopsy Program to allow a personalised medicine approaches for children with high-risk paediatric cancers and have helped focus the Institute for Biomedical Material and Devices (IBMD) to deliver innovative technology solutions for the biomedical sector.

In 2014, I was one of the first to receive the ISAC Shared Resource Laboratory Emerging Leaders (SRL EL) award. During my time as an ISAC SRL EL, I presented multiple workshops and tutorials at CYTOs and was invited to speak in both Korea and China regarding integrating genomics and cytometry. In 2017, with the support of the Australasian Cytometry Society (ACS), I undertook a three-state national speaking tour to advocate for the adoption of an integration of multidisciplinary approaches to science.

I am a member of the ISAC SRL Services Committee, was an author on the SRL best practice paper in 2016 and have been involved in the development of an ISAC SRL recognition program. I am also currently a serving member of the SRL Emerging Leaders Committee, this committee supports emerging SRL leaders. and he has plans to champion the development of a joint SRL, Innovators and Scholars program aimed at closing the gap between these programs and developing real synergy between these parts of the ISAC community.

In my role as Treasurer of the Australasian Cytometry Society (ACS), I was able to increase revenue which was used to underpin education programs and initiatives in the region. I currently serve on the ACS council as the Industry and Innovation Liaison and have spearheaded initiatives to increase engagement across disciplines. This includes collaborative educational activities in the single-cell multi-omics space and the creation of a successful “Shark Tank” technology innovator program.